Phase II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib Meeting Abstract


Authors: Riely, G. J.; Janjigian, Y. Y.; Azzoli, C. G.; Pietanza, M.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Miller, V. A.; Pao, W.; Ginsberg, M. S.
Abstract Title: Phase II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Start Page: 552s
Language: English
ACCESSION: WOS:000208852004690
DOI: 10.1200/jco.2010.28.15_suppl.7557
PROVIDER: wos
Notes: Meeting Abstract: 7557 -- S -- Source: Wos
Altmetric Score
MSK Authors
  1. Michelle S Ginsberg
    155 Ginsberg
  2. Lee M Krug
    204 Krug
  3. Christopher G Azzoli
    102 Azzoli
  4. William Pao
    138 Pao
  5. Naiyer A Rizvi
    150 Rizvi
  6. Maria C Pietanza
    114 Pietanza
  7. Vincent Miller
    253 Miller
  8. Yelena Yuriy Janjigian
    141 Janjigian
  9. Gregory J Riely
    338 Riely
  10. Mark Kris
    586 Kris